| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Director | Common Stock | 10,742 | $1,301,707 | $121.18 | 14 Mar 2025 | Direct |
| INCYTE CORP | Director | Common Stock | 11,252 | $684,684 | $60.85 | 10 Jun 2025 | Direct |
| Lyell Immunopharma, Inc. | Director | Common Stock | 35,640 | $16,750 | $0.4700 | 15 May 2025 | Direct |
| Lyell Immunopharma, Inc. | Director | Option (right to buy) | 130,000 | 15 May 2025 | Direct | ||
| Lyell Immunopharma, Inc. | Director | Option (right to buy) | 130,000 | 14 Jun 2024 | Direct | ||
| PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 22,700 | 11 Jun 2025 | Direct | ||
| INCYTE CORP | Director | Non Qualfied Stock Option (right to buy) | 9,216 | 10 Jun 2025 | Direct | ||
| PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 9,000 | 24 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PDSB | PDS Biotechnology Corp | 11 Jun 2025 | 1 | $0 | 4 | Director | 11 Jun 2025, 18:00 |
| INCY | INCYTE CORP | 10 Jun 2025 | 2 | $0 | 4 | Director | 12 Jun 2025, 16:31 |
| LYEL | Lyell Immunopharma, Inc. | 15 May 2025 | 1 | $0 | 4 | Director | 19 May 2025, 18:45 |
| LYEL | Lyell Immunopharma, Inc. | 31 Mar 2025 | 1 | +$19,958 | 4 | Director | 02 Apr 2025, 15:46 |
| A | AGILENT TECHNOLOGIES, INC. | 14 Mar 2025 | 2 | +$318,825 | 4 | Director | 18 Mar 2025, 09:56 |
| PDSB | PDS Biotechnology Corp | 24 Jun 2024 | 1 | $0 | 4 | Director | 25 Jun 2024, 16:05 |
| LYEL | Lyell Immunopharma, Inc. | 14 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 16:07 |
| INCY | INCYTE CORP | 12 Jun 2024 | 2 | $0 | 4 | Director | 14 Jun 2024, 12:15 |
| A | AGILENT TECHNOLOGIES, INC. | 15 Mar 2024 | 2 | +$358,081 | 4 | Director | 19 Mar 2024, 18:19 |
| LYEL | Lyell Immunopharma, Inc. | 08 Sep 2023 | 1 | $0 | 4 | Director | 08 Sep 2023, 17:22 |
| PDSB | PDS Biotechnology Corp | 14 Jul 2023 | 1 | $0 | 4 | Director | 17 Jul 2023, 17:29 |
| INCY | INCYTE CORP | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:00 |
| A | AGILENT TECHNOLOGIES, INC. | 16 Mar 2023 | 2 | +$328,231 | 4 | Director | 20 Mar 2023, 21:34 |
| PDSB | PDS Biotechnology Corp | 28 Jun 2022 | 1 | $0 | 4 | Director | 29 Jun 2022, 16:15 |
| LYEL | Lyell Immunopharma, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 20 Jun 2023, 16:41 |
| INCY | INCYTE CORP | 15 Jun 2022 | 2 | $0 | 4 | Director | 17 Jun 2022, 16:00 |
| LYEL | Lyell Immunopharma, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:13 |
| A | AGILENT TECHNOLOGIES, INC. | 17 Mar 2022 | 2 | +$353,269 | 4 | Director | 21 Mar 2022, 17:05 |
| A | AGILENT TECHNOLOGIES, INC. | 18 Nov 2021 | 2 | +$94,539 | 4 | Director | 19 Nov 2021, 13:10 |
| A | AGILENT TECHNOLOGIES, INC. | 17 Nov 2021 | 0 | $0 | 3 | Director | 19 Nov 2021, 13:09 |
| INCY | INCYTE CORP | 27 Sep 2021 | 2 | $0 | 4 | Director | 29 Sep 2021, 18:19 |
| INCY | INCYTE CORP | 27 Sep 2021 | 0 | $0 | 3 | Director | 29 Sep 2021, 18:06 |
| PDSB | PDS Biotechnology Corp | 17 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 19:20 |
| LYEL | Lyell Immunopharma, Inc. | 16 Jun 2021 | 0 | $0 | 3 | Director | 16 Jun 2021, 19:14 |